Cargando…
COVID-19 immune response in adults post Measles-Rubella vaccination
OBJECTIVE: This study aimed to see how measles, mumps, and rubella vaccination affected the increase in SARS-CoV-2 immunoglobulin levels in individuals who had received the second dose of the SARS-CoV-2 vaccine. MATERIAL AND METHOD: This research is a quasi-experimental type with a pre-post test des...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192594/ https://www.ncbi.nlm.nih.gov/pubmed/37362839 http://dx.doi.org/10.1016/j.vacun.2023.05.004 |
_version_ | 1785043656569257984 |
---|---|
author | Suwoyo, Suwoyo Yani, Erna Rahma Hardjito, Koekoeh |
author_facet | Suwoyo, Suwoyo Yani, Erna Rahma Hardjito, Koekoeh |
author_sort | Suwoyo, Suwoyo |
collection | PubMed |
description | OBJECTIVE: This study aimed to see how measles, mumps, and rubella vaccination affected the increase in SARS-CoV-2 immunoglobulin levels in individuals who had received the second dose of the SARS-CoV-2 vaccine. MATERIAL AND METHOD: This research is a quasi-experimental type with a pre-post test design. The population studied were adults who had received the second dose of the SARS-CoV-2 vaccine, consisting of 30 people. RESULTS: The results of this study were that most (60%) research subjects experienced an increase in IgM and some subjects (46.6%) experienced an increase in anti-SARS-CoV-2 IgG levels. The administration of the MR vaccination had no effect on increasing anti-SARS-CoV-2 IgG and IgM levels. This happened because the increase in IgM and IgG levels in the pre and post-tests in most research subjects was relatively low. CONCLUSION: The administration of the MR vaccine to adults who had received a second dose of the SARS-CoV-2 vaccine elicited a response with low levels of IgG and IgM SARS-CoV-2. |
format | Online Article Text |
id | pubmed-10192594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101925942023-05-18 COVID-19 immune response in adults post Measles-Rubella vaccination Suwoyo, Suwoyo Yani, Erna Rahma Hardjito, Koekoeh Vacunas Special Article OBJECTIVE: This study aimed to see how measles, mumps, and rubella vaccination affected the increase in SARS-CoV-2 immunoglobulin levels in individuals who had received the second dose of the SARS-CoV-2 vaccine. MATERIAL AND METHOD: This research is a quasi-experimental type with a pre-post test design. The population studied were adults who had received the second dose of the SARS-CoV-2 vaccine, consisting of 30 people. RESULTS: The results of this study were that most (60%) research subjects experienced an increase in IgM and some subjects (46.6%) experienced an increase in anti-SARS-CoV-2 IgG levels. The administration of the MR vaccination had no effect on increasing anti-SARS-CoV-2 IgG and IgM levels. This happened because the increase in IgM and IgG levels in the pre and post-tests in most research subjects was relatively low. CONCLUSION: The administration of the MR vaccine to adults who had received a second dose of the SARS-CoV-2 vaccine elicited a response with low levels of IgG and IgM SARS-CoV-2. Elsevier España, S.L.U. 2023-05-18 /pmc/articles/PMC10192594/ /pubmed/37362839 http://dx.doi.org/10.1016/j.vacun.2023.05.004 Text en © 2023 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Special Article Suwoyo, Suwoyo Yani, Erna Rahma Hardjito, Koekoeh COVID-19 immune response in adults post Measles-Rubella vaccination |
title | COVID-19 immune response in adults post Measles-Rubella vaccination |
title_full | COVID-19 immune response in adults post Measles-Rubella vaccination |
title_fullStr | COVID-19 immune response in adults post Measles-Rubella vaccination |
title_full_unstemmed | COVID-19 immune response in adults post Measles-Rubella vaccination |
title_short | COVID-19 immune response in adults post Measles-Rubella vaccination |
title_sort | covid-19 immune response in adults post measles-rubella vaccination |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192594/ https://www.ncbi.nlm.nih.gov/pubmed/37362839 http://dx.doi.org/10.1016/j.vacun.2023.05.004 |
work_keys_str_mv | AT suwoyosuwoyo covid19immuneresponseinadultspostmeaslesrubellavaccination AT yaniernarahma covid19immuneresponseinadultspostmeaslesrubellavaccination AT hardjitokoekoeh covid19immuneresponseinadultspostmeaslesrubellavaccination |